Head-to-head · WeighScore
Meto vs TeleFirst Med
The verdict
Meto takes it — 62/100 to 57.4/100.
Meto grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Meto | TeleFirst Med |
|---|---|---|
| WeighScore | 62/100 | 57.4/100 |
| Grade | C | C |
| Scorecard rank | #281 | #400 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | 2 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #281 · C
Strengths
- Accepts major insurance (Blue Cross, Anthem, United, Aetna) — most patients pay $0–50 per visit
- Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
- Matches patients with endocrinologists and obesity medicine specialists within minutes
- Offers compounded semaglutide and tirzepatide with board-certified physician oversight
- Handles all prior-auth paperwork; provider location pages exist for all 50 US states
Where it loses points
- Medication pricing fully gated behind quiz — no public cash price for sema or tirz
- Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
- No LegitScript certification or named compounding pharmacy found on any public page
- Company leadership and clinical team not disclosed publicly
- Self-pay cash pricing exists per site copy but is not published anywhere
Graded #400 · C
Strengths
- Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
- Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
- You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
- Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care
Where it loses points
- Only Texas and North Carolina are confirmed — not available nationwide
- The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
- Small practice (about 500 patients) with limited public detail on its clinicians and program
- No compounded or lower-cost medication option, and no medication pricing is published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.